Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSearching for how to dilute semaglutide is understandable, but the answer is straightforward: if you are using a licensed semaglutide medicine in the UK, diluting it yourself is not something you should do, and it is not necessary. Licensed Wegovy pens come pre-filled, pre-dosed, and ready to use exactly as supplied. The need to dilute arises with compounded or unlicensed semaglutide powders — products that should not be part of your treatment in the first place. This page explains why the question exists, what the risks are, and what a properly regulated route to semaglutide treatment actually looks like. Semaglutide is a prescription-only medicine in the UK; a prescriber assesses your suitability before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It is not. This is the single most important thing to say clearly, and then let it go.
The idea that patients need to mix or dilute semaglutide before injecting it has spread through online forums and social media communities, where unlicensed, compounded semaglutide vials (usually supplied as a freeze-dried powder or a concentrated liquid) are discussed as though they are an ordinary alternative to the branded product. They are not. In the UK, the MHRA licenses semaglutide for weight management under the brand name Wegovy, supplied as a pre-filled injection pen with each dose factory-set. There is nothing to prepare, measure or reconstitute.
If a product you have been sold requires dilution before injection, that is a signal about the product itself, not a technique to master. The Wegovy injection as prescribed through a regulated UK pharmacy arrives ready to use. Patients following the licensed treatment pathway do not encounter this step at all. If you are curious about what a properly supervised start to semaglutide treatment looks like, the guide to starting semaglutide covers that in full.
The risks are not theoretical. Diluting a concentrated substance at home introduces several serious possibilities for error: using the wrong diluent, miscalculating the volume, drawing an inaccurate dose from a vial, or contaminating the solution during preparation. Each of these can result in receiving far too little (making treatment ineffective) or far too much, which carries risks including severe gastrointestinal illness, dangerously low blood pressure, or worse.
Beyond dosing arithmetic, there is the question of what is actually in the vial. The MHRA has seized large quantities of fake and unlicensed weight-loss medicines, some of which contained insulin rather than semaglutide. Insulin injected by someone who does not need it and is not monitoring blood glucose can cause life-threatening hypoglycaemia. Reporting concerns about suspect products can be done through the MHRA Yellow Card scheme, which accepts reports from patients as well as healthcare professionals.
The short version: the dilution step is not a skill gap. It is a red flag about the product's origin. If you have encountered instructions telling you how to dilute semaglutide, our semaglutide dilution calculator page explains why that process exists and what it says about the product you have been supplied, and our semaglutide controversy page explores the wider context of unlicensed products in more detail.
Licensed Wegovy is available in the UK through a private prescription from a GPhC-registered pharmacy or, for eligible patients, via NHS specialist weight management services. The NHS semaglutide medicines page outlines how the medicine works and what to expect.
At nume, every consultation is read by a GPhC-registered Independent Prescriber (a real clinician, not an automated system) on the same day you submit it. If treatment is clinically suitable, the licensed product is dispatched the same day for free next-working-day delivery by DPD, in plain packaging. Nothing to mix. Nothing to measure.
For context on what treatment costs through a legitimate private provider, the Wegovy cost page sets out what a transparent private price includes and why the headline figure from an unlicensed seller is rarely a fair comparison. The licensed medicine, clinical oversight and genuine supply chain are part of what you are paying for.
If you are already on treatment and have questions about managing your dose, what stopping looks like, or anything in between, our frequently asked questions are a good starting point, and our clinical team is reachable seven days a week. There is no need to find workarounds when the straightforward, legal route is this accessible.
Ready to speak to a prescriber? Start your free consultation and get a same-day clinical review from a GPhC-registered Independent Prescriber.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.